These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37439934)

  • 41. Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation.
    Bhattacharjee R; Gupta M; Singh T; Sharma S; Khanna G; Parvaze SP; Patir R; Vaishya S; Ahlawat S; Singh A; Gupta RK
    Neuroradiology; 2022 Sep; 64(9):1801-1818. PubMed ID: 35435463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
    Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
    Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
    Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging.
    Hartmann M; Heiland S; Harting I; Tronnier VM; Sommer C; Ludwig R; Sartor K
    Neurosci Lett; 2003 Feb; 338(2):119-22. PubMed ID: 12566167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
    Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H
    J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
    Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D
    Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.
    Scola E; Desideri I; Bianchi A; Gadda D; Busto G; Fiorenza A; Amadori T; Mancini S; Miele V; Fainardi E
    Radiol Med; 2022 Jun; 127(6):664-672. PubMed ID: 35441970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
    Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Kitamura Y; Mizoguchi M; Yoshimoto K; Kuga D; Suzuki SO; Baba S; Isoda T; Iwaki T; Iihara K; Honda H
    J Magn Reson Imaging; 2016 Nov; 44(5):1256-1261. PubMed ID: 27093558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.
    Xu W; Wang Q; Shao A; Xu B; Zhang J
    PLoS One; 2017; 12(3):e0173430. PubMed ID: 28301491
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
    Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic performance of perfusion-weighted imaging combined with serum MMP-2 and -9 levels in tumor recurrence after postoperative concomitant chemoradiotherapy of glioblastoma.
    Liu W; Li Z
    J Clin Ultrasound; 2023 Mar; 51(3):563-570. PubMed ID: 36435971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
    Feng A; Yuan P; Huang T; Li L; Lyu J
    Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discrimination between Glioblastoma and Solitary Brain Metastasis: Comparison of Inflow-Based Vascular-Space-Occupancy and Dynamic Susceptibility Contrast MR Imaging.
    Li X; Wang D; Liao S; Guo L; Xiao X; Liu X; Xu Y; Hua J; Pillai JJ; Wu Y
    AJNR Am J Neuroradiol; 2020 Apr; 41(4):583-590. PubMed ID: 32139428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MR perfusion in and around the contrast-enhancement of primary CNS lymphomas.
    Blasel S; Jurcoane A; Bähr O; Weise L; Harter PN; Hattingen E
    J Neurooncol; 2013 Aug; 114(1):127-34. PubMed ID: 23695516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
    Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
    J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumefactive Primary Central Nervous System Vasculitis: Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging Findings With Histological Correlation.
    Muccio CF; Di Lorenzo L; Lepore G; Savarese F; Schipani S; Chiarotti I; Cerase A
    Clin Ter; 2024; 175(2):112-117. PubMed ID: 38571468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of microvascular permeability with dynamic contrast-enhanced MRI for the differentiation of primary CNS lymphoma and glioblastoma: radiologic-pathologic correlation.
    Kickingereder P; Sahm F; Wiestler B; Roethke M; Heiland S; Schlemmer HP; Wick W; von Deimling A; Bendszus M; Radbruch A
    AJNR Am J Neuroradiol; 2014 Aug; 35(8):1503-8. PubMed ID: 24722313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain.
    Mangla R; Kolar B; Zhu T; Zhong J; Almast J; Ekholm S
    AJNR Am J Neuroradiol; 2011; 32(6):1004-10. PubMed ID: 21511863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.